ANDOVER, Mass., Sept. 15, 2014 /PRNewswire/ -- Royal Philips (NYSE: PHG AEX: PHIA) today announced that its growing range of advanced women's healthcare imaging solutions will be showcased at the 24th annual International Society for Ultrasound in Obstetrics and Gynecology (ISUOG) World Congress, taking place September 14-17 in Barcelona, Spain.
"We're continually investing in clinically relevant solutions that enable clinicians to improve efficiency and outcomes," said Vitor Rocha, CEO and Senior Vice President of Ultrasound for Philips Imaging Systems. "In women's healthcare, we've introduced six dedicated products over the past 18 months that help customers make confident diagnoses for their patients -- from the most complex maternal fetal medicine exams to routine OB/GYN. And we're not stopping there."
At ISUOG, Philips will showcase its full women's healthcare imaging portfolio at booth #31 beginning Sunday, September 14 at 17:20 and running through Wednesday, September 17 at 17:40. Highlights include:
Affiniti is designed to help address the challenges of the everyday OB/GYN clinical working environment. It offers exceptional clinical performance for a busy ultrasound practice, with advanced ergonomic design and small footprint to enable clinicians to work more intuitively and more comfortably.
EPIQ delivers a new level of clinical confidence, with solutions for every gestational age and gynecological applications for your most difficult cases. EPIQ's powerful architecture creates high-quality image resolution, with more diagnostic detail than ever before. And it's simple to use for every patient.
ClearVue 650 offers intuitive 3D/4D imaging and image quality automation tools, such as proprietary Auto Face Reveal, which make it easy for clinicians to integrate 3D/4D in their routine clinical practice. Due to its modular design and lightweight mobile cart, ClearVue 650 is easy to use, energy-efficient and cost-effective.
VISIQ combines the benefits of greater mobility, performance and simplicity into a single miniaturized solution. The transducer-plus-tablet display delivers excellent image quality, making ultrasound available anytime, in a wide range of clinical environments for OB patients.
In addition to showcasing the latest ultrasound solutions, Philips announced a commitment to include international standards for fetal growth on every OB/GYN ultrasound machine in its portfolio. The standards were established by the INTERGROWTH-21st Project, led by Oxford University researchers in collaboration with a consortium of more than 300 researchers and clinicians worldwide. This landmark study, which was recently published in The Lancet, involved a large cohort of healthy, well-nourished, pregnant women from eight geographically diverse populations who were at low risk of adverse maternal and perinatal outcomes. The fetal growth standards complement the existing WHO Child Growth Standards from 0 to 5 years of age and were developed using the same conceptual approach and methods. Philips is proud to have contributed to this work through providing Philips ultrasound systems and technical support.
Throughout the event, Philips and physician partners will also participate in a satellite symposium, live demonstrations and workshops focused on delivering ultrasound solutions designed to meet the demands of today's healthcare world.
Royal Philips (NYSE: PHG, AEX: PHIA) is a diversified health and well-being company, focused on improving people's lives through meaningful innovation in the areas of Healthcare, Consumer Lifestyle and Lighting. Headquartered in the Netherlands, Philips posted 2013 sales of EUR 23.3 billion and employs approximately 113,000 employees with sales and services in more than 100 countries. The company is a leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as male shaving and grooming and oral healthcare. News from Philips is located at www.philips.com/newscenter.